Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

16

Number of overlapping holdings

39.0%

% of HRTS's 41 holdings also in FMED

28.6%

% of FMED's 61 holdings also in HRTS

Overlap by Weight
Sector Drift (HRTS minus FMED)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in HRTS
Weight
in FMED
Overlap
UNITEDHEALTH GROUP INC 6.1% 4.1% 4.1%
BOSTON SCIENTIFIC CORP 3.0% 6.6% 3.0%
ALNYLAM PHARMACEUTICALS INC 2.2% 2.7% 2.2%
EDWARDS LIFESCIENCES CORP 2.0% 2.3% 2.0%
INSULET CORP 1.9% 4.5% 1.9%

Position Highlights (Non-Overlapping Exposures)
HRTS Overweight Relative to FMED
ELI LILLY & CO 7.5%
BRIDGEBIO PHARMA, INC. 4.5%
NOVO NORDISK A/S-B 3.9%
ASTRAZENECA PLC 3.8%
MERCK & CO. INC. 3.6%
ROCHE HOLDINGS LTD-SPONS ADR 3.5%
ABBOTT LABORATORIES 3.3%
CHUGAI PHARMACEUTICAL CO LTD 3.0%
AMGEN INC 2.8%
VERTEX PHARMACEUTICALS INC 2.8%
HRTS Underweight Relative to FMED
INTUITIVE SURGICAL INC -4.6%
BOSTON SCIENTIFIC CORP -3.7%
ARGENX SE ADR -3.6%
EXACT SCIENCES CORP -3.2%
PENUMBRA, INC. -2.8%
UCB SA -2.8%
STRYKER CORP -2.7%
INSULET CORP -2.7%
LIFESTANCE HEALTH GROUP, INC. -2.6%
LEGEND BIOTECH CORPORATION SPONSORED -2.3%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY